PARKIN mutations link melanoma and PD by impairing PARKIN ubiquitination activity and abolishing its tumor suppression effect [270], with the re-expression of PARKIN in melanoma cell lines resulting in reduction in cell proliferation, while the inhibition of PARKIN stimulates the proliferation of melanocytes [271]. Here, PRKN is linked to Parkinson disease.